Decheng Capital

company

About

Decheng Capital is a venture capital firm that provides capital to early and growth stage life science companies.

  • 1 - 10

Details

Industries
Financial Services,Health Care,Venture Capital
Founded date
Jan 1, 2012
Number Of Employee
1 - 10
Operating Status
Active
Investor Type
Venture Capital

Decheng Capital is an investment firm that provides capital and strategic support to early-stage life science companies with revolutionary technologies and growth-stage healthcare companies with a strong market presence. It is a group of dedicated professionals with complementary expertise who have outstanding track records of building highly successful companies globally. Founded in 2012, Decheng continues to capitalize on a historic opportunity in the rapid growth of the healthcare industry as well as breakthroughs in life science research. With over $2 billion in capital under management and support from some of the most prestigious LPs in the world, Decheng is poised to deliver superior returns for our investors and create value for our entrepreneur partners.

Investments

Number of Investments
Number of Lead Investments
12
2
Decheng Capital has made 12 investments. Their most recent investment was on Sep 9, 2021, when Mammoth Biosciences raised $150M.
Date Company Name
Round Money Raised Industry Lead Investor
Series D $150M Biotechnology
May 13, 2021 Cue
Series Unknown $235M Health Care
Series C $120M Biopharma
Series C $45M Biotechnology
Jun 10, 2020 Cue
Series C $102.60M Health Care